Abstract 16099: Predictors of Cardiovascular Implantable Electronic Device-dependence at Long-term Follow-up After Alcohol Septal Ablation in Hypertrophic Cardiomyopathy Patients
Weeranun D. Bode(St David's Medical Center), Theofanie Mela(Harvard University), Michael F. Bode(Massachusetts General Hospital), Rahul Sakhuja(Harvard University), Megan Zhao(Johns Hopkins University), Michael A. Fifer(Massachusetts General Hospital)
Cited by 0
Related Papers
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2023|192
Calciphylaxis: Part I. Diagnosis and pathology
|Journal of the American Academy of Dermatology|2022|40
Ensuring catheter-tissue contact with intracardiac echocardiography during pulsed-field ablation improves procedure outcome in patients with atrial fibrillation
|Heart Rhythm|2025|24
Sex-related differences and hormonal effects in the Dry Eye Assessment and Management (DREAM) study
|British Journal of Ophthalmology|2022|21
Hydration to Prevent Kidney Injury After Pulsed Field Ablation
|JACC. Clinical electrophysiology|2024|21